Theravance Biopharma Inc (TBPH) Stock Price, Quote, News & History

SPY777.22−0.24%QQQ757.08−0.34%BTC/USD83,206.80−2.74%DIA511.54−0.59%GLD377.71−1.19%TLT77.27−0.01%

Theravance Biopharma Inc (TBPH) Stock Price, Quote, News & History

TBPHNASDAQ

Trade with Public

$17.04

0.0140.08%

Last update: Sep 23, 5:58 PM

$17.04

0.0140.08%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

Volume / Avg.

0 / 789.86K

Day Range

- - -

52 Wk Range

13.08 - 21.03

Market Cap

$884.90M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

4.5

Recent Theravance Biopharma Inc News

Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition

Zymeworks will acquire Theravance Biopharma for $929 million, adding YUPELRI cash flows and expanding its portfolio.

Vandana Singh

This Vulcan Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See what analysts think of VMC stock.

Avi Kapoor

Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/downgrades, see analyst ratings page.

Avi Kapoor

Theravance Biopharma Plummets As Phase 3 Study Falls Short

Theravance Biopharma shares tumble after Phase 3 trial fails, company halts drug program and explores sale options ahead of earnings.

Vandana Singh

Crude Oil Surges Over 6%; Target Profit Tops Views

US stocks down amid Iran-US conflict. Tehran closed Strait of Hormuz & warned of firing on vessels. Dow down 2.45%, NASDAQ down 2.62%, S&P 500 down 2.34%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

Volume / Avg.

0 / 789.86K

Day Range

- - -

52 Wk Range

13.08 - 21.03

Market Cap

$884.90M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

4.5

About Theravance Biopharma Inc

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Theravance Biopharma Inc (TBPH) stock?

You can purchase shares of Theravance Biopharma Inc (NASDAQ:TBPH) through any online brokerage.

View our list of the best stock brokerages

Who are Theravance Biopharma Inc (TBPH) competitors?

Other companies in Theravance Biopharma Inc’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

What is the forecast, or price target, for Theravance Biopharma Inc (TBPH) stock?

Theravance Biopharma Inc has a consensus price target of $14.75.

What is the current price for Theravance Biopharma Inc (TBPH)?

The stock price for Theravance Biopharma Inc (NASDAQ: TBPH) is $17.044 last updated September 23, 2026 at 5:58 PM EDT.

Does Theravance Biopharma Inc (TBPH) pay a dividend?

There are no upcoming dividends for Theravance Biopharma Inc.

When is Theravance Biopharma Inc (NASDAQ:TBPH) reporting earnings?

Theravance Biopharma Inc does not have any upcoming earnings scheduled.

Is Theravance Biopharma Inc (TBPH) going to split?

There is no upcoming split for Theravance Biopharma Inc.

What sector and industry does Theravance Biopharma Inc (TBPH) operate in?

Theravance Biopharma Inc is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.